This article is sponsored by Heading Health. In this Voices interview, Behavioral Health Business sits down with Andrea Marquez, Therapy Lead, Heading Health, to talk about the importance of collaboration among patients and diverse provider teams to improve care outcomes and the experience as a whole. She also discusses Heading Health’s approach to treatment innovation […]
This article is sponsored by Heading Health. In this Voices Interview, Behavioral Health Business sits down with Simon Tankel – Founder & Chief Executive Officer, Heading Health, to talk about pioneering in-network ketamine treatments alongside medication management and therapy for better patient solutions. He explains how Heading’s approach differs from traditional providers and provides insight […]
Spark Biomedical secures $16.2M Dallas-based Spark Biomedical disclosed raising $16.2 million of a $21.8 million funding round, according to public documents. The company offers a neurostimulation device that the Food and Drug Administration has cleared to relieve the symptoms of opioid withdrawal. Patients wear a device around their ear for up to 24 hours a […]
Therapeutic ketamine providers are seeing growth and positive patient outcomes, but companies caution that the business requires guardrails as it expands. The drug ketamine was originally invented in the 1960’s as a surgical anesthetic for humans and animals. But ketamine’s dissociative and hallucinogenic properties meant people have also used it recreationally, and more recently, for […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
